Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues - Hagens Berman
The truth emerged on Nov. 27, 2024, when Symbotic revealed errors in its revenue recognition related to unbillable cost overruns. These errors impacted all quarters of fiscal year 2024, with the ...
Symbotic price target lowered to $28 from $34 at Goldman Sachs
Goldman Sachs analyst Mark Delaney lowered the firm’s price target on Symbotic (SYM) to $28 from $34 and keeps a Neutral rating on the shares.
SYM Investors Have Opportunity to Lead Symbotic Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
NDAQ:SYM) SYM Investors Have Opportunity to Lead Symbotic Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm ...